A. D. David Mackay - Dec 31, 2024 Form 4 Insider Report for CLOROX CO /DE/ (CLX)

Role
Director
Signature
By Cheryl Brice, Attorney-in-Fact for
Stock symbol
CLX
Transactions as of
Dec 31, 2024
Transactions value $
$0
Form type
4
Date filed
1/3/2025, 04:35 PM
Previous filing
May 8, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CLX Deferred Stock Units Award $0 +61.4 +0.78% $0.00 7.9K Feb 9, 2024 Common Stock 61.4 Direct F1, F2, F3
transaction CLX Deferred Stock Units Award $0 +66.2 +0.84% $0.00 7.97K May 10, 2024 Common Stock 66.2 Direct F1, F2, F3
transaction CLX Deferred Stock Units Award $0 +61.4 +0.77% $0.00 8.03K Aug 30, 2024 Common Stock 61.4 Direct F1, F2, F3
transaction CLX Deferred Stock Units Award $0 +60.2 +0.75% $0.00 8.09K Nov 7, 2024 Common Stock 60.2 Direct F1, F2, F3
transaction CLX Deferred Stock Units Award $0 +1K +12.37% $0.00 9.09K Dec 31, 2024 Common Stock 1K Direct F1, F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 1-for-1
F2 Deferred Stock Units acquired through dividend reinvestment during the fiscal year pursuant to the Independent Directors' Deferred Compensation Plan.
F3 The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director.
F4 Annual award of Deferred Stock Units pursuant to the 2005 Stock Incentive Plan.